Assignee
CANJI INC
US·35 granted patents·50 pending applications·1,078 citations·filing 1992–2023
Top patents by PatentIndex Score
85 records- 0196US5837520AMethod of purification of viral vectorsCANJI INC·Filed 1995·Granted Nov 17, 1998·170 cites·27 claims
- 0294US5932210ARecombinant adenoviral vector and methods of useCANJI INC·Filed 1997·Granted Aug 3, 1999·151 cites·19 claims
- 0391US6210939B1Recombinant adenoviral vector and methods of useCANJI INC·Filed 1994·Granted Apr 3, 2001·71 cites·25 claims
- 0489US6165779ACompositions and methods for therapeutic useCANJI INC·Filed 1997·Granted Dec 26, 2000·70 cites·9 claims
- 0588US7157079B2Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2004·Granted Jan 2, 2007·32 cites·19 claims
- 0688US6635476B1Targeted vectorsCANJI INC·Filed 2000·Granted Oct 21, 2003·22 cites·26 claims
- 0786US5789244ACompositions and methods for the treatment of cancer using recombinant viral vector delivery systemsCANJI INC·Filed 1996·Granted Aug 4, 1998·70 cites·6 claims
- 0884US7462351B2Nucleic acid deliveryCANJI INC·Filed 2006·Granted Dec 9, 2008·3 cites·26 claims
- 0984US7001770B1Calpain inhibitors and their applicationsCANJI INC·Filed 1999·Granted Feb 21, 2006·78 cites·19 claims
- 1084US2024000968A1Mesothelioma Gene TherapyCANJI INC·Filed 2023·Application pending·0 cites
- 1183US6475481B2Purging of stem cell productsCANJI INC·Filed 1998·Granted Nov 5, 2002·69 cites·52 claims
- 1282US7534769B2Compositions and methods for enhancing delivery of therapeutic agents to cellsCANJI INC·Filed 2002·Granted May 19, 2009·12 cites·67 claims
- 1382US6949379B2Aptamer-mediated regulation of gene expressionCANJI INC·Filed 2001·Granted Sep 27, 2005·34 cites·28 claims
- 1477US8022044B2Compositions and methods for therapeutic useCANJI INC·Filed 2009·Granted Sep 20, 2011·2 cites·21 claims
- 1577US6989268B2Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Granted Jan 24, 2006·5 cites·9 claims
- 1677US6312681B1Compositions and methods for the treatment of cancer using recombinant viral vector delivery systemsCANJI INC·Filed 1997·Granted Nov 6, 2001·30 cites·16 claims
- 1776US7691822B2Methods and compositions for treatment of interferon-resistant tumorsCANJI INC·Filed 2004·Granted Apr 6, 2010·6 cites·2 claims
- 1874US7851218B2Cell lines for production of replication-defective adenovirusCANJI INC·Filed 2005·Granted Dec 14, 2010·3 cites·2 claims
- 1974US6464976B1Methods and compositions for reducing immune responseCANJI INC·Filed 2000·Granted Oct 15, 2002·7 cites·4 claims
- 2074US2021322572A1Methods and compositions for treatment of interferon-resistant tumorsCANJI INC·Filed 2021·Application pending·0 cites
- 2173US7355056B2Transfection agentsCANJI INC·Filed 2004·Granted Apr 8, 2008·10 cites·72 claims
- 2273US6489305B1Methods and compositions for the treatment of ocular diseasesCANJI INC·Filed 1998·Granted Dec 3, 2002·32 cites·25 claims
- 2372US7691370B2Selectivity replicating viral vectorCANJI INC·Filed 2002·Granted Apr 6, 2010·2 cites·16 claims
- 2472US6248514B1Methods for measuring viral infectivityCANJI INC·Filed 1998·Granted Jun 19, 2001·53 cites·28 claims
- 2572US2007253932A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2007·Application pending·0 cites
- 2672US2008194002A1Compositions comprising viruses and methods for concentrating virus preparationsCANJI INC·Filed 2008·Application pending·0 cites
- 2771US2007128166A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 2871US2020164091A1Mesothelioma Gene TherapyCANJI INC·Filed 2020·Application pending·0 cites
- 2970US7157261B2Rat secreted embryonic alkaline phosphataseCANJI INC·Filed 2004·Granted Jan 2, 2007·3 cites·42 claims
- 3070US6392069B2Compositions for enhancing delivery of nucleic acids to cellsCANJI INC·Filed 1998·Granted May 21, 2002·28 cites·5 claims
- 3170US6348352B1Methods for selectively transducing pathologic mammalian cells using a tumor suppressor geneCANJI INC·Filed 1993·Granted Feb 19, 2002·20 cites·3 claims
- 3270US5994134AViral production processCANJI INC·Filed 1998·Granted Nov 30, 1999·33 cites·17 claims
- 3368US7465442B2Reduction of dermal scarringCANJI INC·Filed 2004·Granted Dec 16, 2008·3 cites·7 claims
- 3468US6649158B1Methods and compositions to induce antitumor responseCANJI INC·Filed 1999·Granted Nov 18, 2003·25 cites·5 claims
- 3568US2009148508A1Methods of compositions for the treatment of ocular diseasesCANJI INC·Filed 2008·Application pending·0 cites
- 3667US2006039893A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 3767US2009048148A1Compositions and methods for therapeutic useCANJI INC·Filed 2008·Application pending·0 cites
- 3866US2008286247A1Method for selectively transducing pathologic mammalian cells using a tumor suppressor geneCANJI INC·Filed 2007·Application pending·0 cites
- 3965US2004266006A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2004·Application pending·0 cites
- 4065US2019374654A1Methods and Compositions for Treatment of Interferon-Resistant TumorsCANJI INC·Filed 2018·Application pending·0 cites
- 4165US2006099187A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2005·Application pending·0 cites
- 4265US2007244064A1Methods and compositions to induce antitumor responseCANJI INC·Filed 2006·Application pending·0 cites
- 4364US2009082289A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 4464US2008299083A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2007·Application pending·0 cites
- 4564US2007009486A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 4664US2009088398A1Recombinant adenoviral vectors and methods of useCANJI INC·Filed 2008·Application pending·0 cites
- 4764US2008286239A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2008·Application pending·0 cites
- 4864US2007122379A1Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasmsCANJI INC·Filed 2006·Application pending·0 cites
- 4963US2008182807A1Adenoviral vectors having a protein IX deletionCANJI INC·Filed 2006·Application pending·0 cites
- 5063US2004087027A1Recombinant adenoviral vector and methods of useCANJI INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CANJI INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →